๐ฐ Risk Evaluation News
Page 48 - Risk Evaluation News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Risk Evaluation. Real-time updates on events, politics, business and more.
January 17, 2023
In the first week of 2023, the Biden administration announced two actions centered on expanding access to medication abortion. The first involves a policy change by the FDA...
January 17, 2023
On January 3, the Biden Administration took additional steps to ease access to FDA-approved abortion medication in the United States, further wading into the legal and political chaos...
January 17, 2023
Florida has told pharmacies they may not dispense the abortion pill after the U.S. Food and Drug Administration said it would allow women to obtain chemical abortion drugs over the counter.
January 16, 2023
The FDA recently published its Final Guidance on REMS programs for prescription drugs, which we thought might interest our readers. The document is formally called โFormat and Content...
January 15, 2023
Abortion pill safety regulations created by the U.S. Food and Drug Administration (FDA), known as REMS, are the next target of the profitable abortion industry, which has historically bemoaned all regulations to protect women. The ultimate goal of these abortion advocates โ many associated with Advancing New Standards in Reproductive Health (ANSIRH) โ is to allow over-the-counter dispensing of the abortion pill.
January 14, 2023
Abortion pills are safer than Tylenol, but the FDA is keeping unnecessary barriers to access in place.
January 14, 2023
A group of pro-life doctors are warning about the risks associated with taking abortion pills, especially without medical supervision, after the Food and Drug Administration finalized a Biden administration rule change to make the drugs available at pharmacy chains and mail-order companies nationwide.
January 13, 2023
Catholic leaders decry continuing push for destruction of innocent human lives and loosening of vital safety standards
January 13, 2023
Picture this: The FDA accepts a manufacturer's NDA, and the manufacturer plans for its impending launch. But shortly before the anticipated...
January 13, 2023
In the first week of 2023, the Biden administration announced two actions centered on expanding access to medication abortion. The first involves a policy change by the FDA regarding...